DYNAMic Renal Assessment: NOvel Methods to Assess KIDNEY Functional Reserve
This study, called "DYNAMic Renal Assessment," is exploring new and easier ways to measure how well kidneys work. Current tests often don’t show a problem until a significant amount of kidney function is lost. We know that healthy kidneys can work harder when needed, like after a high-protein meal. This ability is called 'renal reserve.' If this reserve is low, it might be an early sign of kidney issues, even when regular tests look normal. This study aims to compare two new methods of checking this 'dynamic' kidney function against the standard way. The goal is to find more practical methods that could help identify kidney problems earlier, allowing for quicker action to protect kidney health. The intervention being looked at is Dapagliflozin, a medication already used for kidney or heart conditions.
De un vistazo
¿De qué trata este estudio?
When we talk about kidney health, most people think about a test called 'GFR' or 'glomerular filtration rate.' This is typically measured using a blood test called 'serum creatinine.' However, the problem with creatinine is that it often doesn't show a clear problem until a lot of kidney function has already been lost — sometimes up to half! This means that by the time a regular test indicates an issue, the disease could be quite advanced. This study is trying to find better, earlier ways to spot kidney problems.
Think of your kidneys like an engine. A healthy engine can work harder and temporarily boost its performance when you put a demand on it. Similarly, healthy kidneys can increase their activity by up to 25% when challenged, for example, after a big meal with lots of protein. This ability to work harder is called 'renal reserve.' If your kidneys can't respond to this challenge, it might signal an early problem, much like a heart stress test can show issues before you have a heart attack. Losing this reserve is often an early sign that kidney problems are developing or getting worse.
Currently, measuring this renal reserve involves quite a detailed process, often involving special substances and controlled meals. This study wants to compare these traditional, more complex methods with two newer, potentially simpler ways of testing how kidneys respond. By finding easier and more practical tests, doctors might be able to identify kidney issues much earlier than they do now. This could lead to earlier treatment and better ways to protect kidney health over time.
Puntos clave
- Aims to find earlier and more practical ways to detect kidney problems.
- Compares new kidney function tests with current methods.
- Focuses on 'renal reserve' – your kidneys' ability to work harder.
- May involve taking a medication called Dapagliflozin.
- Aimed at helping people with specific kidney conditions or prior kidney donation.
¿Quién puede ser elegible?
This study is looking for people who fit specific criteria. You might be able to join if you have Sickle Cell disease that affects your kidneys, or if you've previously donated a kidney to someone else. You also need to be at least 40 years old. Importantly, you shouldn't have any known allergies or reasons why you shouldn't take the study medication, called Dapagliflozin.
There are also some reasons why you wouldn't be able to join the study. For example, if you are under 40 years old, or if you are pregnant or breastfeeding, you won't be able to take part. Also, if you are currently involved in another research study that involves new treatments, that would stop you from joining this one. The researchers also need to make sure you fully understand what the study involves and are happy to give your permission to take part.
¿Podría este estudio ser adecuado para ti?
Responde estas preguntas rápidas para ver si puedes ser elegible. Esto es solo una guía: el equipo de investigación toma la decisión final.
- ¿Tienes al menos 40 años?
- Do you have Sickle Cell disease affecting your kidneys, or have you donated a kidney?
- ¿No estás embarazada ni amamantando?
- Are you NOT currently part of another clinical trial for a new treatment?
- Do you have no known allergies to the study medication (Dapagliflozin)?
- Are you willing and able to understand and agree to participate?
¿En qué consiste la participación?
If you decide to take part in this study, you would undergo specific tests to measure your kidney function, including the special 'stress tests' that check your kidney reserve. These tests might involve having blood samples taken and possibly collecting urine. You would also be given Dapagliflozin, a medication, and your response would be monitored. The study aims to compare the new testing methods against the existing ones. The total duration of your participation in the study, including all visits and follow-ups, would be explained to you in detail by the study team, but it's focused on assessing these tests rather than long-term treatment outcomes.
Riesgos y beneficios potenciales
Ubicaciones (1)
- Hospital del King's CollegeCódigo postal verificadoLondres, Reino Unido· Reclutamiento
Preguntas comunes
What is 'renal reserve'?
It's your kidney's ability to work harder when needed, like after a meal. Healthy kidneys have this extra capacity.
Why can't current kidney tests spot problems earlier?
Current tests often only show a problem when a significant amount of kidney function has already been lost.
What is Dapagliflozin?
It's a medication that is already used to help manage certain kidney or heart conditions, or diabetes.
Will I have to eat a special meal for the test?
Some tests for renal reserve involve eating a protein-rich meal or similar, to see how your kidneys react.
What is a 'feasibility study'?
It means the study is mainly checking if these new testing methods are practical and possible to use in real life.
Cómo obtener más información
Kate Bramham, Doctor
Siempre hable con su médico de cabecera o especialista antes de decidir participar en un estudio.
¿Interesado en participar?
Discusión
Discusión comunitaria
Impulsado por nuestro foro en community.patient.info. Por favor, sea respetuoso — esto no es un consejo médico.